NCT05107219 2026-04-07
GCC Agonist Signal in the Small Intestine
University of Wisconsin, Madison
Phase 1 Completed
Clinical Trials
9 trialsNCT03205501 2024-04-16
EAGLE
University Medical Center Groningen
Phase 1 Completed
NCT03589443 2019-08-05
Study of Multiplexed Heptapeptides for Detection of Neoplasia in the Esophagus
University of Michigan
Phase 1 Completed
NCT01630798 2015-10-08
NTR 1B
University of Michigan
Phase 1 Completed
NCT01238042 2014-12-02
Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity For PDT Treatment Of High Grade Dysplasia,CIS or Early Adenocarcinoma In Barrett's Esophagus
Roswell Park Cancer Institute
Phase 1 Completed
NCT00233935 2014-09-11
Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus
National Cancer Institute (NCI)
Phase 1 Completed
NCT01236443 2014-01-13
Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus
Roswell Park Cancer Institute
Phase 1 Completed
NCT00573911 2013-01-17
Acid Reflux and Stromal Fibroblasts in Barrett's Esophagus
Mayo Clinic
Phase 1 Completed
NCT01391208 2012-10-11
Esophageal Protocol for Detection of Neoplasia in the Digestive Tract
University of Michigan
Phase 1 Completed